Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Active Rheumatoid Arthritis

In brief

The purpose of this study is to evaluate the safety and efficacy of ATN-103 when administered to subjects with active rheumatoid arthritis compared with placebo. All subjects must be on a stable dose and route of methotrexate.

Key facts

Study ID

NCT00959036

Run by

Ablynx, a Sanofi company

People needed

252

Starts

2009-09-01

Expected to finish

2011-01-01

Last updated by the study team

2013-01-30

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of active rheumatoid arthritis on a stable background of methotrexate (7.5-25 mg weekly).

You may not qualify if…

• Any significant health problem other than rheumatoid arthritis
• Any clinically significant laboratory abnormalities
• Any prior use of B cell-depleting therapy

Where it is running

• Investigational Site — Huntsville, Alabama, United States
• Investigational Site — Peoria, Arizona, United States
• Investigational Site — Scottsdale, Arizona, United States
• Investigational Site — Riverside, California, United States
• Investigational Site — Upland, California, United States
• Investigational Site — Bridgeport, Connecticut, United States
• Investigational Site — Newark, Delaware, United States
• Investigational Site — Lake Mary, Florida, United States
• Investigational Site — Ocala, Florida, United States
• Investigational Site — Orlando, Florida, United States
• Investigational Site — Port Orange, Florida, United States
• Investigational Site — Vero Beach, Florida, United States
• Investigational Site — Coeur d'Alene, Idaho, United States
• Investigational Site — Frederick, Maryland, United States
• Investigational Site — West Yarmouth, Massachusetts, United States
• Investigational Site — Lansing, Michigan, United States
• Investigational Site — Freehold, New Jersey, United States
• Investigational Site — Albuquerque, New Mexico, United States
• Investigational Site — Mineola, New York, United States
• Investigational Site — Charlotte, North Carolina, United States
• Investigational Site — Hickory, North Carolina, United States
• Investigational Site — Winston-Salem, North Carolina, United States
• Investigational Site — Winston-Salem, North Carolina, United States
• Investigational Site — Columbus, Ohio, United States
• Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.